Symbols / CMAX $0.42
CMAX Chart
About
No company description available for this symbol.
Fundamentals
Scroll to Statements| Sector | — | Industry | — | Market Cap | — |
| Enterprise Value | — | Income | — | Sales | — |
| Book/sh | — | Cash/sh | — | Dividend Yield | — |
| Payout | — | Employees | — | IPO | — |
| P/E | — | Forward P/E | — | PEG | — |
| P/S | — | P/B | — | P/C | — |
| EV/EBITDA | — | EV/Sales | — | Quick Ratio | — |
| Current Ratio | — | Debt/Eq | — | LT Debt/Eq | — |
| EPS (ttm) | — | EPS next Y | — | EPS Growth | — |
| Revenue Growth | — | Earnings | 2024-08-09 17:00 | ROA | — |
| ROE | — | ROIC | — | Gross Margin | — |
| Oper. Margin | — | Profit Margin | — | Shs Outstand | — |
| Shs Float | — | Short Float | — | Short Ratio | — |
| Short Interest | — | 52W High | — | 52W Low | — |
| Beta | — | Avg Volume | — | Volume | — |
| Target Price | — | Recom | — | Prev Close | $0.00 |
| Price | $0.42 | Change | — |
Valuation Models
Price estimates from analyst targets and simple models.
1. Analyst consensus
—
Mean price target
2. Current target
—
Latest analyst target
3. DCF / Fair value
—
Simplified FCF or EPS-based estimate
Ratings
Current target
—
Low
—
High
—
Mean
—
Latest analyst rating changes
| Date | Action | Analyst | Rating Change | Price Target |
|---|---|---|---|---|
| 2024-04-01 | main | UBS | Neutral → Neutral | $6 |
- Gelteq (GELS) gel platform boosts antihistamine bioavailability 38–45% in preclinical study - Stock Titan Mon, 24 Nov 2025 08
- Private Equity in Healthcare – PESP’s November 2024 Roundup - Private Equity Stakeholder Project PESP Mon, 02 Dec 2024 08
- CareMax Restructures Amidst Bankruptcy and Delisting Challenges - Nasdaq Mon, 25 Nov 2024 08
- Aussie trial breakthrough for eye disease - insightnews.com.au hu, 30 Oct 2025 07
- CMAX ALERT: Levi & Korsinsky, LLP Commences an Investigation of CareMax, Inc. (CMAX) f/k/a Deerfield Healthcare Technology Acquisitions Corp. (DFHT) - PR Newswire ue, 12 Mar 2024 07
- Camurus (STO: CAMX) Announces Phase 1b Data: CAM2056 Achieves 9.3% Weight Loss, Monthly - Stock Titan Mon, 10 Nov 2025 08
- Sebi cautions investors on stock market scams through social media platforms - ETLegalWorld.com Wed, 21 May 2025 07
- Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Monday - InvestorPlace Mon, 12 Aug 2024 07
- CareMax hopes to avoid bankruptcy after Nasdaq delist warning - The Business Journals ue, 01 Oct 2024 07
- PAS-004 Has Tolerable Safety Profile and Preliminary Efficacy in MAPK-Driven Solid Tumors - OncLive Fri, 27 Sep 2024 07
- Steward goes All-in on Value-Based Care with CareMax - Hospitalogy ue, 07 Jun 2022 07
- Medical services provider CareMax files for Chapter 11 restructuring - Reuters Mon, 18 Nov 2024 08
- New Melotime melatonin study results from Nutriventia show healthy sleep pattern support - Nutritional Outlook ue, 11 Mar 2025 07
- Steward Health Care Appoints Rubén José King-Shaw Jr to Its Board of Directors - The Globe and Mail hu, 07 Jul 2022 07
- Two men in their 20s hospitalised with serious injuries following M40 crash - Oxford Mail Mon, 19 May 2025 07
Insider Transactions
No recent insider transactions.
Financials
No financial statements available. Data is sourced from Yahoo Finance and cached; historical storage may be added later.
SEC Filings
No SEC filings found for this symbol (may be non-US or ticker not in SEC index).
Public Trades for CMAX
| Date | User | Broker | Pattern | Type | Position Size | Entry Price | Trade P&L | Status |
|---|